Arcutis Biotherapeutics, Inc.  (Nasdaq: ARQT)

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)

arcutis.com

research

Westlake Village, California, United States
201-500 employees
212819000 revenue

About Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)

biotechnology, medical dermatology, drug development, inflammation, immunology, clinical trials, topical drugs, bioscience, commercialization, plaque psoriasis, atopic dermatitis, eczema, biotechnology: pharmaceutical preparations, health care, biotechnology research, pde4 inhibitors, dermatology drug development, topical skin therapies, dermatology therapeutic innovation, skin inflammation biologics

Decision Makers at Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)

2 contacts

Rajvir Madan

SVP and Chief Digital and Information Technology Officer

r***@arcutis.com Sign up to view

Raja Mikkili

Head of Core Technology and Security

r***@arcutis.com Sign up to view

Unlock full contact details including verified emails and LinkedIn profiles

Upgrade to Pro
24 technologies detected · 2 decision makers · Emails available

Sales Outreach Angle

CRMs like Salesforce signal an active sales operation. Companies using Salesforce are strong targets for sales training, RevOps tools, data enrichment, and Salesforce integrations.

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)'s Position in the StackWho Database

  • Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is 1 of 7,925 research companies tracked in StackWho.
  • 7,883 research companies in our database have verified decision-maker emails (99% of the cohort).
  • 53,147 companies in California are in the StackWho database.
  • 278 research companies are in the 201-500 employee range (same size as Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)).

Technology detection from public web signals. Decision-maker contacts compiled from LinkedIn public profiles, company filings, and verified outbound testing. Methodology & sources · Updated July 2026.

Frequently Asked Questions

What technology does Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) use?

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) uses Salesforce, DNS Made Easy, Outlook, Pantheon, Atlassian Cloud, OneTrust, and 18 more technologies. This data is sourced from StackWho's technology detection engine.

How do I contact the decision makers at Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)?

StackWho has verified email addresses for 2 decision makers at Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT). Pro members can access direct emails for the CEO, CTO, VP of Engineering, and other key contacts. Use StackWho to reach Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) directly for sales, recruiting, or partnerships.

What industry is Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) in?

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) operates in the research industry, headquartered in Westlake Village, California, United States. StackWho tracks technology stacks and decision maker contacts for companies across all industries.

Can I export Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)'s contact data?

Yes. StackWho Pro members can export decision maker contact data for Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) and similar companies to CSV. Use the export feature to build targeted prospect lists segmented by technology stack, industry, or location.